LVGO - 3 Top Diabetes Stocks to Watch in January
Diabetes is a massive market in the healthcare sector. An estimated 415 million people have diabetes worldwide, and those numbers are growing. It's also an on-going healthcare issue, one that patients have to manage, often for the rest of their lives. As such, there is a lot of recurring revenue. It's not a bad idea to find a strong company focused on this vertical to add to your portfolio.
Over the last decade, one of the biggest stocks in healthcare has been diabetes specialist DexCom (NASDAQ: DXCM), a wireless health company that allows patients and doctors to track glucose levels in real-time. Another potential winner in this space is Livongo Health (NASDAQ: LVGO), an up-and-coming small-cap that sends updates, reminders, and coaching tips to all its clients with diabetes (and other health issues). And biotech company Provention Bio (NASDAQ: PRVB) is hoping to get approval from the Food and Drug Administration (FDA) for a drug that delays the onset of type 1 diabetes. Read more to see if any of these stocks are buys right now.
Image source: Getty Images